Judi O’Malley, a medical device expert who spent 11 years as a vascular physiologist with the HSE, founded Spiorad Medical in mid 2021. Picture by Fergal Phillips
The company was founded in mid-2021 by Judi O’Malley, a medical device expert who spent 11 years as a vascular physiologist with the HSE, and Dr Samer Arnous, a cardiologist with particular expertise in complex coronary and structural heart interventions. The firm already has seven staff members on board and has ambitions to carve out a niche for itself in the vascular closure market, which is valued at more than €1 billion. It is planning to begin animal trials this year and conduct human trials by the end of 2023. By 2024, the company expects to employ 22 staff members.
Patients with cardiovascular issues often undergo a procedure where a catheter is inserted into the femoral artery, the main blood vessel supplying blood to the lower body. After catheterisation, the artery has to be closed up, but O’Malley said the options available on the market come with issues. “I really wanted to offer something that was easier to use, and that would mitigate that risk,” she said.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: businessposthq - 🏆 8. / 71 더 많은 것을 읽으십시오 »
출처: businessposthq - 🏆 8. / 71 더 많은 것을 읽으십시오 »
Business angels invest average of €200,000 in start-upsA new survey from the Halo Business Angel Network shows that HBAN business angels have invested a median of €200,000 each in start-ups on the island of Ireland.
출처: RTEbusiness - 🏆 16. / 61 더 많은 것을 읽으십시오 »
출처: businessposthq - 🏆 8. / 71 더 많은 것을 읽으십시오 »
출처: businessposthq - 🏆 8. / 71 더 많은 것을 읽으십시오 »